AER under FFDCA sec. 760 - nonprescription drug products

Postmarketing Adverse Drug Experience Reporting

0636 GFI on AER for NonRx Human Drug Products

AER under FFDCA sec. 760 - nonprescription drug products

OMB: 0910-0230

Document [html]
Download: html
File Typeinode/x-empty
File Modified0000-00-00
File Created0000-00-00

© 2025 OMB.report | Privacy Policy